Target Name: MIR199A2
NCBI ID: G406977
Review Report on MIR199A2 Target / Biomarker Content of Review Report on MIR199A2 Target / Biomarker
MIR199A2
Other Name(s): hsa-miR-199a-5p | hsa-mir-199a-2 | MIR-199-s | hsa-miR-199a-3p | mir-199a-2 | MicroRNA 199a-2 | MIRN199A2 | microRNA 199a-2

MIR199A2: A Potential Drug Target and Biomarker

MIR199A2 (hsa-miR-199a-5p) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study, and a number of studies have investigated its potential as a drug.

MIR199A2 is a microRNA (miRNA), a small non-coding RNA molecule that plays a critical role in regulating gene expression. It is composed of 199 amino acid residues and has a calculated molecular weight of 21 kDa. MIR199A2 is expressed in a variety of tissues and cells in the body, including tissues of the brain, heart, liver, and cancer cells.

One of the key features of MIR199A2 is its ability to interact with other molecules and proteins. It has been shown to interact with a variety of protein partners, including nuclear factor kappa B (NFkB), which is a protein that plays a critical role in regulating cellular processes such as inflammation, cell growth, and survival.

MIR199A2 has also been shown to play a role in regulating gene expression. Studies have shown that MIR199A2 can bind to specific target genes and regulate their expression levels. For example, MIR199A2 has been shown to repress the expression of the gene encoding the protein p53, which is a well-known tumor suppressor gene.

In addition to its potential role in gene regulation, MIR199A2 has also been shown to play a role in cellular signaling. It has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and invasion.

MIR199A2 has also been shown to have potential as a drug target in cancer. Studies have shown that MIR199A2 is expressed in a variety of cancer cells and that it is involved in the regulation of cellular processes that are critical for cancer cell growth and survival. For example, MIR199A2 has been shown to play a role in the regulation of the angiogenic factor, which is a protein that promotes the formation of new blood vessels that can provide oxygen and nutrients to cancer cells.

In addition to its potential as a drug target, MIR199A2 has also been shown to have potential as a biomarker. Studies have shown that MIR199A2 can be used as a biomarker for a variety of diseases, including cancer. For example, MIR199A2 has been shown to be expressed in a variety of cancer types, including breast, lung, and ovarian cancer.

In conclusion, MIR199A2 is a non-coding RNA molecule that has a unique structure and function. Its ability to interact with other molecules and proteins, as well as its role in gene regulation and cellular signaling, make it an attractive target for research and as a potential drug or biomarker. Further studies are needed to fully understand the potential of MIR199A2 as a drug target and biomarker for various diseases.

Protein Name: MicroRNA 199a-2

The "MIR199A2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR199A2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A | MIR200B | MIR200C | MIR200CHG | MIR202 | MIR202HG | MIR203A | MIR203B | MIR204 | MIR205 | MIR2052 | MIR2052HG | MIR2053 | MIR2054 | MIR205HG | MIR206 | MIR208A | MIR208B | MIR20A | MIR20B | MIR21 | MIR210 | MIR210HG | MIR211 | MIR2110 | MIR2113 | MIR2114 | MIR2115 | MIR2116 | MIR2117 | MIR212 | MIR214 | MIR215 | MIR216A | MIR216B | MIR217 | MIR217HG | MIR218-1 | MIR218-2 | MIR219A1 | MIR219A2 | MIR219B | MIR22 | MIR221 | MIR222 | MIR223 | MIR224 | MIR2276 | MIR2277 | MIR2278 | MIR22HG | MIR2355 | MIR2392 | MIR23A | MIR23AHG | MIR23B | MIR23C | MIR24-1 | MIR24-2 | MIR2467 | MIR25 | MIR2681 | MIR2682 | MIR26A1 | MIR26A2 | MIR26B | MIR27A | MIR27B | MIR28 | MIR2861 | MIR2909 | MIR296 | MIR297 | MIR298 | MIR299 | MIR29A | MIR29B1 | MIR29B2 | MIR29B2CHG | MIR29C | MIR300 | MIR301A | MIR301B | MIR302A | MIR302B | MIR302C | MIR302D | MIR302E | MIR302F | MIR3059 | MIR3064 | MIR3065 | MIR3074 | MIR3085 | MIR30A | MIR30B